Saroglitazar

Generic Name
Saroglitazar
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C25H29NO4S
CAS Number
495399-09-2
Unique Ingredient Identifier
E0YMX3S4JD
Background

Saroglitazar has been investigated for the treatment of Fatty Liver.

Associated Conditions
-
Associated Therapies
-

A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities

First Posted Date
2023-05-24
Last Posted Date
2024-02-07
Lead Sponsor
Zydus Lifesciences Limited
Target Recruit Count
1500
Registration Number
NCT05872269
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

Gastroplus Digestive Disease Centre, Ahmedabad, India

๐Ÿ‡ฎ๐Ÿ‡ณ

Medanta- TheMedicity, Gurgaon, India

๐Ÿ‡ฎ๐Ÿ‡ณ

Mission GastroHospital, Ahmedabad, India

and more 16 locations

Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)

Phase 2
Completed
Conditions
Interventions
First Posted Date
2018-08-21
Last Posted Date
2024-10-24
Lead Sponsor
Zydus Therapeutics Inc.
Target Recruit Count
20
Registration Number
NCT03639623
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Virginia Commonwealth University, Richmond, Virginia, United States

A Prospective, Randomized Trial to Compare saroGLitazar With pioglitAZone in Nonalcoholic Fatty livEr Disease

First Posted Date
2014-10-15
Last Posted Date
2014-10-16
Lead Sponsor
Command Hospital, India
Target Recruit Count
100
Registration Number
NCT02265276
Locations
๐Ÿ‡ฎ๐Ÿ‡ณ

Command Hospital, Panchkula, Haryana, India

ยฉ Copyright 2024. All Rights Reserved by MedPath